Martin S. Wadley

Charles Hastings Way, 
Worcester, ENG, GB 
Charles Hastings Way, 
Worcester, ENG, GB 

Overview

Martin Wadley practices practicing medicine in Worcester, United Kingdom.

His clinical expertise encompasses Gallstones, Cholecystitis, Esophageal Cancer, Pseudotumor Cerebri Syndrome, and Gallbladder Removal.

He is actively involved in clinical research, co-authoring 10 peer reviewed articles and participating in 1 clinical trial.

Gender

Male

Locations

Charles Hastings Way, Worcester, ENG, United Kingdom

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

Neo-AEGIS (NEOadjuvant Trial in Adenocarcinoma of the oEsophagus and oesophagoGastric Junction International Study): Randomised Clinical Trial of Neoadjuvant and Adjuvant Chemotherapy (Modified MAGIC or FLOT Regimen) vs. Neoadjuvant Chemoradiation (CROSS Protocol) in Adenocarcinoma of the Oesophagus and Oesophago-gastric Junction
Neo-AEGIS (NEOadjuvant Trial in Adenocarcinoma of the oEsophagus and oesophagoGastric Junction International Study): Randomised Clinical Trial of Neoadjuvant and Adjuvant Chemotherapy (Modified MAGIC or FLOT Regimen) vs. Neoadjuvant Chemoradiation (CROSS Protocol) in Adenocarcinoma of the Oesophagus and Oesophago-gastric Junction
Enrollment Status: Completed
Publish Date: September 30, 2022
Intervention Type: Radiation, Drug
Study Drugs: Epirubicin, Cisplatin / Oxaliplatin, 5 Flourouracil/ Capecitabine, Paclitaxel, Carboplatin, Docetaxel, Oxaliplatin, Leucovorin, 5-Fluorouracil
Study Phase: Phase 3

10 Total Publications

Trimodality therapy versus perioperative chemotherapy in the management of locally advanced adenocarcinoma of the oesophagus and oesophagogastric junction (Neo-AEGIS): an open-label, randomised, phase 3 trial.
Trimodality therapy versus perioperative chemotherapy in the management of locally advanced adenocarcinoma of the oesophagus and oesophagogastric junction (Neo-AEGIS): an open-label, randomised, phase 3 trial.
Journal: The lancet. Gastroenterology & hepatology
Published: June 23, 2023

Frequently Asked Questions about Martin S. Wadley

Is Martin S. Wadley a top-rated expert for Gallbladder Removal?

MediFind is an objective health platform that identifies experts based on real-world data. Martin S. Wadley is classified as an Experienced expert for Gallbladder Removal, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Martin S. Wadley participate in research or clinical trials?

Yes. Martin S. Wadley has published 10 articles and abstracts on conditions like Gallbladder Removal. You can view a list of Martin S. Wadley's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Wadley's expertise for a condition
ConditionClose
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile